(Q47975596)

English

Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo

scientific article published in January 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

Trypanosoma cruzi

0 references

Plasmodium berghei

0 references

Entamoeba histolytica

1 reference

based on heuristic

inferred from title

author name string

W Raether

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

H Seidenath

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

Zeitschrift für Parasitenkunde (Berlin, Germany)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

70

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

135-138

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

In Vitro Susceptibility of Antimony-Resistant Leishmania to Alternative Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/6320547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica

1 reference

https://pubmed.ncbi.nlm.nih.gov/6320547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/6320547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imidazole and Polyene Activity Against Chloroquine-Resistant Plasmodium falciparum

1 reference

https://pubmed.ncbi.nlm.nih.gov/6320547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketoconazole-induced drop in serum and saliva testosterone

1 reference

https://pubmed.ncbi.nlm.nih.gov/6320547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral Ketoconazole in the Treatment of Leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/6320547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00929583

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/6320547

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47975596&oldid=2179685216"